Candida Overgrowth Baseline
Placeholder: normal flora balance disrupted, yeast overgrows.
- 100%: Baseline load (Placeholder unit)
- Yeast: Cell form (Budding form)
- High: Growth rate (Placeholder)
- Day 0: Symptom onset (Placeholder)
Overgrowth dynamics
Placeholder: short note on Candida overgrowth baseline conditions.
Hyphal Form Proliferation
Placeholder: yeast-to-hyphae transition drives tissue invasion.
- ↑↑: Hyphal length (Placeholder)
- High: Invasiveness (Placeholder)
- Forming: Biofilm (Placeholder)
- pH/temp: Trigger (Placeholder)
Hyphal transition
Placeholder: short note on hyphal proliferation mechanism.
Antifungal Drug Mechanism (Ergosterol)
Placeholder: azoles inhibit ergosterol synthesis, weakening membrane.
- 14-DM: Target enzyme (Lanosterol demethylase)
- Ergosterol: Membrane sterol (Placeholder)
- Azole: Drug class (Placeholder)
- Topical/oral: Route (Placeholder)
Ergosterol pathway block
Placeholder: short note on azole ergosterol inhibition mechanism.
Fungal Load Reduction
Placeholder: sustained treatment reduces fungal burden over days.
- Exp. decay: Reduction curve (Placeholder)
- Faster: Oral onset (Placeholder)
- Slower: Topical onset (Placeholder)
- <5%: Target load (Placeholder)
Load decline kinetics
Placeholder: short note on fungal load reduction over treatment.
Symptom Resolution Timeline
Placeholder: symptoms fade as fungal load clears fully.
- 1-3 days: Oral cure (Placeholder)
- 7 days: Topical cure (Placeholder)
- Low-Med: Relapse risk (Placeholder)
- Recommended: Follow-up (Placeholder)
Resolution timeline
Placeholder: short note on symptom resolution timeline.
Placeholder: complete full treatment course to prevent relapse.